Inventory / revenue moved 6160 bp higher
Inventory / revenue changed +6160 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +6160 basis points from the comparable as-filed period.
Gross profit changed -28.7% from the comparable as-filed period.
Free-cash-flow margin changed +6702 basis points from the comparable as-filed period.
Operating cash-flow margin changed +5329 basis points from the comparable as-filed period.
Working capital / assets changed -598 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed -3122 basis points from the comparable as-filed period.
Cost of revenue changed -17.7% from the comparable as-filed period.
Current ratio changed -23.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -4.9% from the comparable as-filed period.
Current liabilities changed -4.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed +2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.